Literature DB >> 35558979

Whole-exome sequencing establishes a diagnosis of Alstrom syndrome: a case report.

Ziqin Liu1, Xiaobo Chen1.   

Abstract

Background: Alstrom syndrome (ALMS) is a rare genetic disorder. ALMS is characterized by progressive bilateral sensorineural hearing impairment, cone-rod dystrophy, infantile-onset cardiomyopathy, hypertriglyceridemia, accelerated non-alcoholic fatty liver disease, renal dysfunction and insulin-resistant diabetes mellitus (DM). DM typically develop in childhood or adolescence. Dilated cardiomyopathy may arise in infancy. Clinical symptoms appear with great variability and severity. Several cases have been reported worldwide; however, diagnosis remains challenging. Case Description: We report an 8-year-and-11-month-old female diagnosed with ALMS who had a long history of obesity and amblyopia from infancy. We found high levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in this patient. She showed no hearing disfunction. Recently, she presented with sudden-onset insulin-resistant DM. Genetic analysis revealed the heterozygous mutations c.8366delT, p.L2789* and c.6829C>T, p.R2277*. c.8366delT, which results in premature protein termination, has not been reported previously in ALMS1. Although the patient's two sisters died of acute heart failure following infection at 4 and 14 months respectively, she showed no signs of cardiomyopathy until now. Conclusions: This case provides an unusual cause of genetic syndrome associated with diabetes. A detailed medical history, physical examination and appropriate gene analysis are critical for diagnosis. Our case identifies a novel ALMS1 mutation and reaffirms the great clinical variation of this disease even within families. 2022 Translational Pediatrics. All rights reserved.

Entities:  

Keywords:  ALMS1 gene; Alstrom syndrome (ALMS); case report; diabetes

Year:  2022        PMID: 35558979      PMCID: PMC9085958          DOI: 10.21037/tp-21-623

Source DB:  PubMed          Journal:  Transl Pediatr        ISSN: 2224-4336


  25 in total

1.  A novel ALMS1 splice mutation in a non-obese juvenile-onset insulin-dependent syndromic diabetic patient.

Authors:  May Sanyoura; Cédric Woudstra; George Halaby; Patrick Baz; Valérie Senée; Pierre-Jean Guillausseau; Pierre Zalloua; Cécile Julier
Journal:  Eur J Hum Genet       Date:  2013-05-08       Impact factor: 4.246

2.  Homozygosity mapping at Alström syndrome to chromosome 2p.

Authors:  G B Collin; J D Marshall; L R Cardon; P M Nishina
Journal:  Hum Mol Genet       Date:  1997-02       Impact factor: 6.150

3.  The progression from obesity to type 2 diabetes in Alström syndrome.

Authors:  Vera Bettini; Pietro Maffei; Claudio Pagano; Sara Romano; Gabriella Milan; Francesca Favaretto; Jan D Marshall; Richard Paisey; Francesco Scolari; Nella A Greggio; Ilaria Tosetto; Jürgen K Naggert; Nicola Sicolo; Roberto Vettor
Journal:  Pediatr Diabetes       Date:  2011-07-03       Impact factor: 4.866

Review 4.  The phenotypic and molecular genetic spectrum of Alström syndrome in 44 Turkish kindreds and a literature review of Alström syndrome in Turkey.

Authors:  Ayşegül Ozantürk; Jan D Marshall; Gayle B Collin; Selma Düzenli; Robert P Marshall; Şükrü Candan; Tülay Tos; İhsan Esen; Mustafa Taşkesen; Atilla Çayır; Şükrü Öztürk; İhsan Üstün; Esra Ataman; Emin Karaca; Taha Reşid Özdemir; İlknur Erol; Fehime Kara Eroğlu; Deniz Torun; Erhan Parıltay; Elif Yılmaz-Güleç; Ender Karaca; M Emre Atabek; Nursel Elçioğlu; İlhan Satman; Claes Möller; Jean Muller; Jürgen K Naggert; Rıza Köksal Özgül
Journal:  J Hum Genet       Date:  2014-10-09       Impact factor: 3.172

5.  Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle.

Authors:  K Poetter; H Jiang; S Hassanzadeh; S R Master; A Chang; M C Dalakas; I Rayment; J R Sellers; L Fananapazir; N D Epstein
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

6.  Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere.

Authors:  L Thierfelder; H Watkins; C MacRae; R Lamas; W McKenna; H P Vosberg; J G Seidman; C E Seidman
Journal:  Cell       Date:  1994-06-03       Impact factor: 41.582

7.  Body fat distribution, serum glucose, lipid and insulin response to meals in Alström syndrome.

Authors:  R B Paisey; D Hodge; K Williams
Journal:  J Hum Nutr Diet       Date:  2008-06       Impact factor: 3.089

Review 8.  Clinical and Mechanistic Insights Into the Genetics of Cardiomyopathy.

Authors:  Michael A Burke; Stuart A Cook; Jonathan G Seidman; Christine E Seidman
Journal:  J Am Coll Cardiol       Date:  2016-12-27       Impact factor: 24.094

9.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

10.  Consensus clinical management guidelines for Alström syndrome.

Authors:  Natascia Tahani; Pietro Maffei; Hélène Dollfus; Richard Paisey; Diana Valverde; Gabriella Milan; Joan C Han; Francesca Favaretto; Shyam C Madathil; Charlotte Dawson; Matthew J Armstrong; Adrian T Warfield; Selma Düzenli; Clair A Francomano; Meral Gunay-Aygun; Francesca Dassie; Vincent Marion; Marina Valenti; Kerry Leeson-Beevers; Ann Chivers; Richard Steeds; Timothy Barrett; Tarekegn Geberhiwot
Journal:  Orphanet J Rare Dis       Date:  2020-09-21       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.